The recent report in The Lancet Haematology, led by Cleveland Clinic hematologist Dr. Bethany Samuelson Bannow, sheds light on the critical need for improved blood care for women and girls worldwide. While it might seem like a straightforward issue, the report reveals a complex web of challenges and opportunities that demand our attention and action. Personally, I think this report is a wake-up call for the global health community, highlighting the stark inequities in women's blood-related health and the urgent need for change. What makes this particularly fascinating is the report's emphasis on the often-overlooked aspects of women's health, such as heavy menstrual bleeding and postpartum hemorrhage, which can be the first signs of underlying bleeding disorders. In my opinion, this report is a call to action for all of us to re-evaluate our approach to women's health and hematology. One thing that immediately stands out is the staggering delay in diagnosing bleeding disorders in women, with an average wait time of 14 to 16 years, compared to just two years for men. This delay has profound implications, as it can lead to delayed treatment and potentially life-threatening complications. What many people don't realize is that this delay is not just a matter of access to healthcare, but also a reflection of the societal norms and biases that influence how women's health is perceived and addressed. If you take a step back and think about it, this delay is a symptom of a larger issue: the underrecognition and understudying of women's health issues. This raises a deeper question: how can we address this delay and improve the diagnosis and treatment of bleeding disorders in women? From my perspective, the report's recommendations provide a roadmap for action. The goal to reduce the average time from symptom onset to diagnosis to less than 24 months by 2035 is ambitious but achievable. What this really suggests is that we need to prioritize women's health and hematology in our research, policy, and clinical care. The report calls for universal screening for heavy menstrual bleeding and iron deficiency, standardized postpartum hemorrhage protocols, and more personalized thrombosis care during pregnancy and the postpartum period. These recommendations are not just about improving healthcare outcomes, but also about promoting equity and justice in women's health. However, the report also highlights the need for stronger investment in women's health, updated clinical guidelines, and greater inclusion of women in research. This is where the real challenge lies: how can we ensure that these recommendations are not just words on paper, but are translated into tangible actions and changes on the ground? In my view, the key lies in coordination and collaboration across clinical care, research, and education. We need to work together to develop and implement evidence-based practices that address the unique challenges faced by women and girls with hematological conditions. We also need to raise awareness and educate both healthcare providers and the public about the importance of early diagnosis and treatment for bleeding disorders. The publication of this commission represents an important milestone for women's health and hematology. Women experience unique challenges related to bleeding and clotting disorders throughout their lives, yet many aspects of their care remain underrecognized or understudied. This commission provides an important resource for clinicians, researchers, policymakers, and advocates to improve outcomes globally. However, the report also serves as a reminder that we have a long way to go. We need to continue to advocate for women's health and hematology, and push for the kind of coordinated action that can make a real difference in the lives of women and girls around the world. In conclusion, the report in The Lancet Haematology is a powerful reminder of the critical need for improved blood care for women and girls. It is a call to action for all of us to re-evaluate our approach to women's health and hematology, and to work together to develop and implement evidence-based practices that can make a real difference. Personally, I am hopeful that this report will spark a global conversation and lead to meaningful progress in women's health and hematology. But I am also aware of the challenges that lie ahead, and the need for sustained commitment and action to address the inequities in women's blood-related health.
